Niagen Bioscience
NAGE
60 hedge funds and large institutions have $45.8M invested in Niagen Bioscience in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 7 closing their positions.
91% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 11
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
3% more funds holding
Funds holding: 58 → 60 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.31% less ownership
Funds ownership: 19.86% → 19.55% (-0.31%)
11% less capital invested
Capital invested by funds: $51.2M → $45.8M (-$5.47M)
17% less call options, than puts
Call options by funds: $52K | Put options by funds: $63K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$571K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$542K |
| 3 |
TCM
Tieton Capital Management
Yakima,
Washington
|
+$423K |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$416K |
| 5 |
BlackRock
New York
|
+$347K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
-$474K |
| 2 |
UIC
Uniplan Investment Counsel
Milwaukee,
Wisconsin
|
-$152K |
| 3 |
SIM
Spark Investment Management
New York
|
-$70K |
| 4 |
JP Morgan Chase
New York
|
-$67.2K |
| 5 |
CPIG
Chicago Partners Investment Group
Chicago,
Illinois
|
-$67K |
NAGE Hedge Fund Activity: Q3 2019 in Review
60 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q3 2019, worth a combined $45.8M — down 11% from $51.2M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new NAGE positions and 7 closed out — a net gain of 2 holders — while 21 added to existing stakes and 11 trimmed.
The largest buyer was Millennium Management, adding an estimated $571K. The largest seller was Sargent Investment Group, exiting entirely with an estimated $474K sold.
- 60 institutional investors held Niagen Bioscience (NAGE) as of Q3 2019, up from 58 in Q2 2019.
- Funds reported $45.8M of Niagen Bioscience stock for Q3 2019, down 11% quarter-over-quarter.
- 9 funds opened new Niagen Bioscience positions in Q3 2019 and 7 closed out, a net change of +2 holders.
- The largest Niagen Bioscience buyer in Q3 2019 was Millennium Management, an estimated $571K added.
- The largest Niagen Bioscience seller in Q3 2019 was Sargent Investment Group, an estimated $474K sold.
Based on aggregated 13F filings for Q3 2019.